From the Divisions of Nephrology and Critical Care Medicine (KDL) and the Division of Pulmonary and Critical Care Medicine (MAM), University of California San Francisco, San Francisco, CA; the Pulmonary and Critical Care Unit (BTT), Departments of Medicine and Biostatistics (MA), Massachusetts General Hospital, Boston, MA; the Division of Critical Care Medicine (JSS), Baystate Medical Center, Springfield, MA, and Tufts University School of Medicine, Boston, MA; the Division of Pulmonary Sciences and Critical Care Medicine (ISD), University of Colorado and Denver Health Medical Center, Denver, CO; Pulmonary and Critical Care Medicine (PW), Moses Cone Hospital, Greensboro, NC; the Department of Medicine (MWP), University of California San Francisco at Fresno, Fresno, CA; the Department of Anesthesiology (PR), University of Maryland, Baltimore, MD; Pulmonary and Critical Care Medicine (RCH), University of Michigan, Ann Arbor, MI; Pulmonary and Critical Care Medicine (AA), South Texas Veterans Health Care System and University of Texas Health Sciences Center at San Antonio, San Antonio, TX; and the Division of Pulmonary and Critical Care Medicine (JDT), University of Virginia, Charlottesville, VA.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (http://www.ccmjournal.com).
All authors were supported by contracts NO1-HR-46046-64 and NO1-HR-16146-54 with the National Heart, Lung, and Blood Institute, National Institutes of Health. K.D.L. was supported by National Institutes of Health/National Center for Research Resources/OD University of California–San Francisco–CTSI Grant Number KL2 RR024130.
Dr. Wright received honoraria/speaking fees from GlaxoSmithKline. The remaining authors have not disclosed any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]